Want to receive a bonus share in this company? Find out how to get one!

Karan Dsij
/ Categories: Trending, Mindshare
Want to receive a bonus share in this company? Find out how to get one!

However, no need to panic! It’s just a corporate-related adjustment, which has led to such a fall in its stock price! 

Ajanta Pharma Limited is a speciality pharmaceutical company engaged in developing, producing & marketing a range of branded and generic formulations.  

 

Have you checked the stock price of Ajanta Pharma this morning? You’ll be shocked to see that it has tanked almost 34 per cent! However, no need to panic! It’s just a corporate-related adjustment, which has led to such a fall in its stock price! 

The shares of the pharmaceutical company has turned ex-bonus today as its board announced a bounce issue of 1:2 but the record date has been set as June 23, 2022.   

If you are one of them who are confused regarding the concept of record and ex-date, we will help you to understand it in an easy way.   

To determine whether or not you’ll be entitled to receive a bonus share, you need to look at two important dates. One is an ex-date and the second one is a record date.   

First, we will start with the ex-date. An ex-date is usually set one trading session prior to the record date and on this day, the price is adjusted but why does it happen so? It is because we follow T+2 days as our trading cycle. Meanwhile, the record date is the date set by the company under which the investor owns shares by that date to be qualified for a bonus share announced by the company.   

Investors, who hold shares on the record date, are entitled to get a bonus share of the company.   

Hence, if you are an investor who wishes to receive a bonus share in the pharmaceutical company, you can still receive it as the record date is on June 23 (Thursday).   

Rate this article:
3.9

DSIJ MINDSHARE

Mkt Commentary20-Dec, 2024

Swing Trading22-Dec, 2024

IPO Analysis20-Dec, 2024

Mindshare20-Dec, 2024

IPO Analysis20-Dec, 2024

Knowledge

MF15-Nov, 2024

General15-Nov, 2024

MF14-Nov, 2024

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR